In part three of AHA’s five-part series on opioid stewardship, Marie Cleary-Fishman, AHA’s vice president of clinical quality, speaks with Holly Geyer, M.D., hospital internal medicine practitioner sub-specialized in addiction medicine at Mayo Clinic, about the roots of the opioid epidemic and the state and federal requirements — and institutional protocols — for developing solutions. LISTEN HERE.


View the whole series.

Related News Articles

Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
The Centers for Disease Control and Prevention today released updated guidelines for clinicians prescribing opioids to outpatients for short- or long-term…
Headline
In this episode – part four of AHA’s five-part series on opioid stewardship – Marie Cleary-Fishman, AHA’s vice president of clinical quality, is joined once…
Headline
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in…
#HealthCareInnovation Thursday Blog
How could I have been so unprepared? I held my 3-year-old’s hand tighter than a pediatrician would approve of as together we watched paramedics resuscitate…
Headline
The Food and Drug Administration seeks comments through June 21 on a potential change that would require outpatient settings to dispense opioid pain…